Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  CounterPath, Corp.    CPAH   US22228P2039

COUNTERPATH, CORP. (CPAH)

0
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period April 201220132014201520162017
Sales14,115,211,714,818,2-
Operating income (EBITDA)--1,19-3,90-2,56-1,57-
Operating profit (EBIT)--1,42-4,13-2,89-2,70-
Pre-Tax Profit (EBT)-0,47-5,90-3,26-2,41-
Net income-2,120,47-5,91-3,26-2,41-
EPS ( $)-0,050,01-0,14-0,07-0,06-
Dividend per Share ( $)------
Yield------
Announcement Date07/19/2012
02:00am
07/25/2013
12:30pm
07/10/2014
01:42pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period April 201220132014201520162017
Debt------
Finance------
Operating income (EBITDA)--1,19-3,90-2,56-1,57-
Leverage
(Debt/EBITDA)
------
Capital Expenditure-0,26----
Book Value Per Share (BVPS)------
Cash Flow per Share------
Announcement Date07/19/2012
02:00am
07/25/2013
12:30pm
07/10/2014
01:42pm
---
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 32,2 M$ -
Entreprise Value (EV) - 32,2 M$
Valuation 2015e 2016e
PER (Price / EPS)
Capitalization / Revenue 2,18x 1,77x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) - -
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) -19,6% -14,8%
operating Leverage (Delta EBIT / Delta Sales) 1,14x 0,29x
Net Margin (Net Profit / Revenue) -22,1% -13,3%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   - -
Cash Flow / Sales (Taux d'autofinancement) - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend
Dynamic quotes  
ON
| OFF